Tecomet is a leading provider of high precision manufacturing solutions for orthopedic implants, as well as critical components for the cardiovascular, medical imaging and aerospace markets. Its core capabilities include forging, coating, casting, precision machining, photochemical etching, welding and finishing. Tecomet has the largest breadth of offerings among orthopedic outsourced manufacturers and deep partnerships with many blue-chip customers, including some of the nation’s leading medical and aerospace & defense OEMs.
The May 2017 transaction marks Charlesbank’s second acquisition of Tecomet, both times in partnership with management. Charlesbank first purchased the company in a complex corporate carve-out in 2008, expanding its business capabilities, customer base and reputation for innovation before selling it in late 2013 to the current seller.
Interim CEO – Bill Dow
Headquartered in Wilmington, MA, Tecomet operates 16 global manufacturing centers in five countries.